Culturally Adapted Parenting Intervention for Spanish-Speaking Parents in Improving Outcomes of Younger Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia Survivors at Risk for Late Neurocognitive Effects



Status:Active, not recruiting
Conditions:Cancer, Cancer, Blood Cancer, Hematology
Therapuetic Areas:Hematology, Oncology
Healthy:No
Age Range:Any
Updated:9/8/2018
Start Date:October 22, 2015
End Date:August 2019

Use our guide to learn which trials are right for you!

Adaptation and Pilot-Testing a Parenting Intervention for Spanish-Speaking Parents of Children at Risk for Neurocognitive Late Effects

This pilot clinical trial studies a culturally adapted skills training and educational
intervention in guiding parents of younger acute lymphoblastic leukemia (ALL) or acute
myeloid leukemia (AML) survivors at risk for long-term attention and memory problems (late
neurocognitive effects). ALL and AML treatments target the central nervous system and may put
younger survivors at increased risk for late neurocognitive effects, which may lead to
learning difficulties or behavior problems and poor health-related quality of life.
Spanish-speaking parents of young ALL or AML survivors may not have access to the
information, resources, or guidance to help their children through these difficulties.
Adapting an existing parent-training program into Spanish may help teach Spanish-speaking
parents effective ways to prevent or reduce learning and behavioral difficulties, which may
improve the quality of life of parents and young ALL or AML survivors.

PRIMARY OBJECTIVES:

I. To culturally modify and adapt an existing educational and skills-training intervention
for use with Spanish-speaking parents of children with acute lymphoblastic leukemia (ALL) or
with acute myeloid leukemia (AML).

II. To pilot the culturally-modified, parenting intervention with eligible families of
children treated for ALL or AML in the Pediatrics department at City of Hope.

OUTLINE:

PHASE I (FOCUS GROUPS): Parents undergo a semi-structured interview with bilingual research
assistants over 120 minutes. The content and purpose of the intervention is explained, and
the focus group discussions elicit feedback on the intervention components and content of the
sessions, and whether the material is culturally and linguistically appropriate. Following
the focus group discussion, parents receive a copy of the educational handouts that they may
choose to use with their child if they like.

PHASE II (PILOT TESTING): Parents of children age 5 to 17 years, 11 months old undergo
adapted skills training in Spanish over 60 minutes (8 training sessions total) or 80 minutes
(6 training sessions total). The adapted skills training sessions focus on parenting
strategies and learning techniques. Sessions include homework assignments and techniques for
parents to apply with their child for at least 30 minutes, 3 times a week at home.

After completion of study, parents are followed up every 2 weeks for 3 months and at 6 and 12
months.

Inclusion Criteria:

INCLUSION CRITERIA FOR FOCUS GROUPS (PHASE I)

- Parents or adult primary caregiver (e.g., grandmother) of children ages 5 to 17 in
treatment remission and has completed intensive therapy for ALL or AML

- Parents of childhood cancer survivors who are now 18 years or older and who were
previously treated for ALL or AML (do not need to live with the child)

- One or both of the parents will self-identify as Hispanic/Latino, the primary
participating parent will be either Spanish speaking, bilingual, or is bilingual but
identifies their primary language as English and will live with the child

INCLUSION CRITERIA FOR PILOT-TESTING (PHASE II)

- Parent/Caregiver: parents or adult primary caregiver (e.g., grandmother) of children
treated for ALL or AML

- Parent/Caregiver: one or both of the parents will self-identify as Hispanic/Latino,
the primary participating parent will be either Spanish speaking, bilingual, or is
bilingual but identifies their primary language as English and will live with the
child

- Child: child is in treatment remission and has completed intensive therapy

- Child: child is age 5 to 17 years, 11 months

- Child: child understands English

Exclusion Criteria:

EXCLUSION CRITERIA FOR FOCUS GROUPS (PHASE I)

- Parents of ALL or AML survivors with a history of a major psychiatric condition that
precludes participation (e.g., psychosis, severe depression, active substance abuse)

- Existing history of severe cognitive impairment in the child as reported by the
parents or documented in the child's City of Hope medical records

EXCLUSION CRITERIA FOR PILOT TESTING (PHASE II)

- Parent/Caregiver: parents with a history of a major psychiatric condition that
precludes participation (e.g., psychosis, severe depression, active substance abuse)

- Child: survivors with a history of a major psychiatric condition that precludes
participation (e.g., psychosis, severe depression, active substance abuse)

- Child: existing history of severe cognitive impairment (intelligence quotient [IQ] =<
70) as reported by the parents or the child's City of Hope medical records, or by the
child's performance score on the Wechsler Intelligence Scale for Children (WISC)
Working Memory and Processing Speed index measures administered in this study
We found this trial at
1
site
Duarte, California 91010
Principal Investigator: Sunita K. Patel
Phone: 626-301-8426
?
mi
from
Duarte, CA
Click here to add this to my saved trials